Akari Therapeutics PLC
NASDAQ:AKTX
Akari Therapeutics PLC
NASDAQ:AKTX
Price:
4.47
USD
-3.87%
Market Closed
Market Cap:
$5.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
US |
|
Storm Exploration Inc
OTC:CWVWD
|
CA |
|
A
|
Ahresty Corp
TSE:5852
|
JP |
|
N
|
Ningbo Heli Technology Co Ltd
SSE:603917
|
CN |
|
M
|
Milux Corporation Bhd
KLSE:MILUX
|
MY |
|
S
|
Shoei Co Ltd
TSE:3483
|
JP |
|
Draytek Corp
TWSE:6216
|
TW |
Balance Sheet
Balance Sheet Decomposition
Akari Therapeutics PLC
Akari Therapeutics PLC
Balance Sheet Decomposition is not available for
Akari Therapeutics PLC
Akari Therapeutics PLC
Balance Sheet
Akari Therapeutics PLC
Akari Therapeutics PLC
Currency: USD
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
8
|
3
|
69
|
34
|
28
|
5
|
6
|
14
|
9
|
13
|
4
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
6
|
14
|
9
|
13
|
4
|
3
|
|
| Cash Equivalents |
0
|
0
|
1
|
8
|
3
|
69
|
34
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
2
|
1
|
1
|
2
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
1
|
8
|
3
|
70
|
46
|
29
|
7
|
6
|
15
|
12
|
14
|
4
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Total Assets |
0
N/A
|
0
N/A
|
1
+3 633%
|
8
+599%
|
3
-57%
|
70
+1 962%
|
46
-34%
|
29
-37%
|
8
-72%
|
6
-19%
|
15
+125%
|
12
-20%
|
14
+19%
|
4
-69%
|
51
+1 061%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
4
|
2
|
2
|
2
|
1
|
3
|
2
|
1
|
2
|
12
|
|
| Accrued Liabilities |
0
|
1
|
1
|
0
|
0
|
0
|
2
|
5
|
1
|
4
|
2
|
3
|
3
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
16
|
8
|
5
|
2
|
1
|
0
|
1
|
8
|
1
|
1
|
|
| Total Current Liabilities |
1
|
2
|
4
|
1
|
1
|
21
|
12
|
12
|
5
|
6
|
5
|
6
|
12
|
5
|
20
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Other Liabilities |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+23%
|
4
+78%
|
2
-55%
|
1
-42%
|
21
+1 709%
|
12
-44%
|
12
+1%
|
5
-59%
|
6
+32%
|
5
-19%
|
6
+17%
|
12
+98%
|
5
-62%
|
28
+518%
|
|
| Equity | ||||||||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
11
|
18
|
18
|
23
|
24
|
32
|
0
|
0
|
1
|
1
|
5
|
|
| Retained Earnings |
11
|
13
|
17
|
21
|
11
|
57
|
75
|
110
|
127
|
165
|
130
|
148
|
165
|
175
|
195
|
|
| Additional Paid In Capital |
8
|
10
|
13
|
26
|
2
|
87
|
91
|
105
|
107
|
134
|
140
|
153
|
167
|
175
|
213
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
2
N/A
|
2
-25%
|
3
-35%
|
6
N/A
|
2
-62%
|
49
+2 095%
|
34
-30%
|
17
-50%
|
3
-82%
|
0
-100%
|
9
+93 700%
|
6
-41%
|
2
-68%
|
0
N/A
|
22
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
1
+3 633%
|
8
+599%
|
3
-57%
|
70
+1 962%
|
46
-34%
|
29
-37%
|
8
-72%
|
6
-19%
|
15
+125%
|
12
-20%
|
14
+19%
|
4
-69%
|
51
+1 061%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
12
|
12
|
13
|
40
|
722
|
1 178
|
1 178
|
1 526
|
1 581
|
2 246
|
3 847
|
4 760
|
7 445
|
13 234
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
